Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Rohto, Mitsui to Buy Singapore’s Chinese Medicine Firm for SGD800 Million
April 5, 2024
- Nippon Shinyaku, MiNA Therapeutics Join Hands in Rare CNS Disorders
April 5, 2024
- Healios Snaps Up Assets after Athersys’ Bankruptcy Filing
April 5, 2024
- Tarlige Winner in February GP Rep Promotion Rankings
April 4, 2024
- Taisho’s Positive PIII Data Set Stage for Japan Filing of Insomnia Med
April 4, 2024
- FDA OKs First Digital Therapeutic App for Depression: Otsuka
April 4, 2024
- Chugai Offers 5% Pay Raise in 30-Year-Old Model Case
April 4, 2024
- Mochida, Meiji Adds China for Epadel Sales Collaboration
April 4, 2024
- Eisai to Divest Rights to 2 CNS Drugs to UK’s CNX in France, Algeria
April 4, 2024
- Sawai Closes Sale of US Business to Taiwan CDMO
April 4, 2024
- Sumitomo Offloads Entire Stake in Roivant as Earnings Tank
April 3, 2024
- Daiichi’s TROP2 ADC Accepted for US FDA Review in Breast Cancer
April 3, 2024
- Axcelead-Teijin Drug Discovery Joint Venture Now Up and Running
April 2, 2024
- MS Med Copaxone Transferred to Teva Takeda Pharma
April 2, 2024
- Takeda to Hand Over Nihon Pharma to Alinamin in July
April 2, 2024
- Cheplapharm to Take Over 5 Brands from Clinigen in Japan
April 2, 2024
- Aculys Pharma Poaches Takeda Veteran as New CEO
April 2, 2024
- New Ono Chief Eager to Go Solo in US, Europe; BTK Med 1st Shield against Opdivo Patent Cliff
April 1, 2024
- Ying Chen Named as President of Bayer Holding in Japan
April 1, 2024
- Asahi Kasei Grabs Japan Commercial Rights to Doptelet’s ITP Use
April 1, 2024
